We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans.

Mutations in leucine-rich repeat kinase 2 (LRRK2) cause autosomal-dominant familial Parkinson's disease. We generated lines of Caenorhabditis elegans expressing neuronally directed human LRRK2. Expressing human LRRK2 increased nematode survival in response to rotenone or paraquat, which are agents that cause mitochondrial dysfunction. Protection by G2019S, R1441C, or kinase-dead LRRK2 was less than protection by wild-type LRRK2. Knockdown of lrk-1, the endogenous ortholog of LRRK2 in C. elegans, reduced survival associated with mitochondrial dysfunction. C. elegans expressing LRRK2 showed rapid loss of dopaminergic markers (DAT::GFP fluorescence and dopamine levels) beginning in early adulthood. Loss of dopaminergic markers was greater for the G2019S LRRK2 line than for the wild-type line. Rotenone treatment induced a larger loss of dopamine markers in C. elegans expressing G2019S LRRK2 than in C. elegans expressing wild-type LRRK2; however, loss of dopaminergic markers in the G2019S LRRK2 nematode lines was not statistically different from that in the control line. These data suggest that LRRK2 plays an important role in modulating the response to mitochondrial inhibition and raises the possibility that mutations in LRRK2 selectively enhance the vulnerability of dopaminergic neurons to a stressor associated with Parkinson's disease.

Pubmed ID: 19625511 RIS Download

Mesh terms: Aging | Animals | Animals, Genetically Modified | Caenorhabditis elegans | Dopamine | Gene Knockdown Techniques | Herbicides | Insecticides | Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | Mitochondria | Mortality | Mutation | Neurons | Paraquat | Protein-Serine-Threonine Kinases | RNA, Messenger | Rotenone

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NIEHS NIH HHS, Id: ES015567
  • Agency: Intramural NIH HHS, Id: R01 NS041786
  • Agency: NINDS NIH HHS, Id: R01 NS060872
  • Agency: NINDS NIH HHS, Id: R01 NS060872-01A2
  • Agency: NINDS NIH HHS, Id: R01 ES015567-01A2
  • Agency: NIEHS NIH HHS, Id: R01 NS041786-01
  • Agency: NINDS NIH HHS, Id: R01 ES015567
  • Agency: NIEHS NIH HHS, Id: NS060872
  • Agency: NINDS NIH HHS, Id: R01 ES015567-04
  • Agency: NIEHS NIH HHS, Id: Z01 AG000953
  • Agency: NIA NIH HHS, Id:

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.